Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • skin cancer

Tag: skin cancer

  • BiotechToday
  • World

Metastatic melanoma: Dual treatment to fight

bioxone July 15, 2021July 14, 2021

Monika R, PSG College of Technology, Coimbatore Melanoma is a deadly skin cancer that is said to occur mainly because of the accumulation of mutations in growth-regulating genes, the loss of adhesion receptors, and the increase in autocrine and paracrine growth factors- all of which contribute to uncontrolled proliferation promoting the survival of those abnormal […]

Read More
  • BiotechToday
  • World

ENGINEERED ONCOLYTIC ADENOVIRUS TO TREAT METASTATIC CANCER

bioxone December 2, 2020December 2, 2020 4

Husna, Amity University Kolkata Oncolytic viruses are genetically engineered for the destruction of cancer or tumour-causing cells specifically. They’re delivered for treatment inside the body via intravenous injection. In 2015, one such oncolytic virus was approved by the FDA for treating skin cancer, melanoma. A major obstacle in the application of oncolytic adenoviruses is that […]

Read More
  • BiotechToday
  • World

Xeroderma Pigmentosum: A Reason of Depriving Man of His Right to Sunlight

bioxone October 27, 2020October 27, 2020

Sayantani  Halder,Amity University Kolkata Xeroderma Pigmentosum (XP) is a rare inherited human syndrome (recessive autosomal trait), caused due to the defect in mechanism of repairing of damaged DNA (or mutated DNA) characterized by hypersensitivity to sunlight, developing skin cancer at a very early age. The primary cause of this disease is the absence of a […]

Read More
  • BiotechToday
  • India

SKIN CANCER KILLING BANDAGE DEVELOPED BY IISc

bioxone October 9, 2020October 9, 2020 2

Rohit Bhattacharjee, Amity University Kolkata Skin cancer, the most common kind of cancer, is mainly caused due to excessive exposure to the UV rays from the sun. They are of two types:- melanoma ( develops from pigment-producing skin cells called melanocytes) and non-melanoma (developed from other skin cells). Though non-melanoma skin cancer is more widespread, […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy